Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
Hepatology. 2014 Oct;60(4):1211-21. doi: 10.1002/hep.27289.
Hepatology. 2014.
PMID: 25043514
Clinical Trial.
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
Scorletti E, West AL, Bhatia L, Hoile SP, McCormick KG, Burdge GC, Lillycrop KA, Clough GF, Calder PC, Byrne CD.
Scorletti E, et al. Among authors: mccormick kg.
J Hepatol. 2015 Dec;63(6):1476-83. doi: 10.1016/j.jhep.2015.07.036. Epub 2015 Aug 10.
J Hepatol. 2015.
PMID: 26272871
Clinical Trial.
Item in Clipboard
Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.
McCormick KG, Scorletti E, Bhatia L, Calder PC, Griffin MJ, Clough GF, Byrne CD.
McCormick KG, et al.
Diabetologia. 2015 Aug;58(8):1916-25. doi: 10.1007/s00125-015-3628-2. Epub 2015 May 29.
Diabetologia. 2015.
PMID: 26021488
Clinical Trial.
Item in Clipboard
Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial.
Clough GF, McCormick KG, Scorletti E, Bhatia L, Calder PC, Griffin MJ, Byrne CD.
Clough GF, et al. Among authors: mccormick kg.
Diabetologia. 2016 Jul;59(7):1422-1429. doi: 10.1007/s00125-016-3966-8. Epub 2016 Apr 22.
Diabetologia. 2016.
PMID: 27106721
Clinical Trial.
Item in Clipboard
Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Calder PC, Byrne CD; WELCOME Trial Investigators.
Scorletti E, et al. Among authors: mccormick kg.
Contemp Clin Trials. 2014 Mar;37(2):301-11. doi: 10.1016/j.cct.2014.02.002. Epub 2014 Feb 18.
Contemp Clin Trials. 2014.
PMID: 24556343
Clinical Trial.
Item in Clipboard
Self-management approaches to reduce the ill-health burden associated with musculoskeletal foot and ankle problems: A scoping review protocol.
Cherry L, Gates L, McCormick K, Culliford D, Portillo MC, Walker-Bone K.
Cherry L, et al.
Musculoskeletal Care. 2020 Dec;18(4):541-545. doi: 10.1002/msc.1479. Epub 2020 Jun 11.
Musculoskeletal Care. 2020.
PMID: 32529754
Review.
Item in Clipboard
Cite
Cite